1. What Is GHRP-6?

GHRP-6 is a synthetic met-enkephalin analog that was discovered when Bowers and colleagues observed that certain chemical modifications of enkephalin amides produced unexpected growth hormone-releasing activity in pituitary cell cultures. The resulting hexapeptide specifically and dose-dependently released GH both in vitro and in vivo through a mechanism entirely distinct from growth hormone-releasing hormone (GHRH). This was a landmark finding: it demonstrated that a second, independent pathway for GH secretion existed at the pituitary level.

The peptide's amino acid sequence, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2, includes two D-amino acids (D-Trp and D-Phe), which confer resistance to enzymatic degradation and contribute to its receptor binding affinity. Its molecular formula is C₄₆H₅₆N₁₂O₆ with a molecular weight of 873.0 g/mol.

GHRP-6 acts as an agonist at the growth hormone secretagogue receptor 1a (GHS-R1a), which was later identified as the ghrelin receptor after Kojima and colleagues discovered ghrelin as its endogenous ligand in 1999. This makes GHRP-6 a functional ghrelin mimetic. It activates the same receptor that the body's primary hunger hormone acts on, which explains its potent orexigenic (appetite-stimulating) effects.